Interstitial brachytherapy of the prostate with Pd-103 and iodine-125, toxicity comparison and results after 6.5 years

被引：0
|
作者：
Oismueller, R.
Somay, C.
Buehler, F.
Ponholzer, A.
Hawliczek, R.
Maderbacher, St.
Rauchenwald, M.
机构：
[1] SMZ Ost Donauspital, Inst Radioonkol & Strahlentherapie, Vienna, Austria
[2] SMZ Ost Donauspital, Abt Urol, Vienna, Austria
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2006年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：194 / 194
页数：1
相关论文
共 50 条
  • [1] Interstitial Brachytherapy of the prostate with Pd-103 and Jod-125, toxicity comparison and results after 8 years
    Oismueller, R.
    Somay, C.
    Poljanc, K.
    Futschek, B.
    Futschek, T.
    Ponholzer, A.
    Hawliczek, R.
    Maderbacher, S.
    Rauchenwald, M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 171 - 172
  • [2] Interstitial Brachytherapy of the prostate with Pd 103 and Jod 125, results and toxicity comparison after 7.5 years
    Oismueller, R.
    Somay, C.
    Hartl, R.
    Hawliczek, R.
    Ponholzer, A.
    Madersbacher, S.
    Rauchenwald, M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 43 - 43
  • [3] Different activities of iodine-125 seeds in interstitial permanent prostate brachytherapy: A comparison
    Mulhern, AD
    Maurer, U
    Pinkawa, M
    Gagel, B
    Block, T
    Borchers, H
    [J]. RADIOLOGY, 2001, 221 : 179 - 179
  • [4] Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125
    Shirvani, Shervin M.
    Kudchadker, Rajat J.
    Bruno, Teresa L.
    Likhacheva, Anna
    Swanson, David A.
    Frank, Steven J.
    [J]. BRACHYTHERAPY, 2011, 10 (04) : 269 - 274
  • [5] Toxicity of PD 103 and I 125 after interstitial brachytherapy? A statistical analysis after a follow-up of 5 years
    Oismueller, R.
    Poljanc, K.
    Somay, C.
    Futschek, T.
    Schmidt, W. F. O.
    Buechler, F.
    Futschek, B.
    Ponholzer, A.
    Madersbacher, S.
    Rauchenwald, M.
    Aiginger, H.
    Hawliczek, R.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S458 - S458
  • [6] Predicting the Severity of Acute Urinary Toxicity after Brachytherapy with Iodine-125 for Localized Prostate Cancer
    Takeda, Ken
    Jingu, Keichi
    Koto, Masashi
    Fujimoto, Keisuke
    Narazaki, Kakutaro
    Kubozono, Masaki
    Saito, Hideo
    Yamada, Shigeyuki
    Mitsuduka, Kohji
    Ishidoya, Shigeto
    Ariga, Hisanori
    Arai, Yoichi
    Yamada, Shogo
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 223 (01): : 55 - 60
  • [7] Pd-103 and I-125 dose comparison for delivered ocular brachytherapy plans
    Larocque, Matthew
    Weis, Ezekiel
    Menon, Geetha
    [J]. MEDICAL PHYSICS, 2017, 44 (08) : 4385 - 4386
  • [8] PSA PROFILE OF CURED PATIENTS AFTER IODINE-125 PROSTATE BRACHYTHERAPY
    Crook, J.
    Gomez, A.
    Ma, C.
    McLean, M.
    Fung, S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S7 - S8
  • [9] Expansion and regression of prostate volume after permanent brachytherapy with iodine-125
    Messer, PM
    Goufried, HW
    Schneider, E
    Waletzko, O
    Hautmann, R
    Röttinger, EM
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 42 - 42
  • [10] There is a wide range of predictive dosimetric factors for I-125 and Pd-103 prostate brachytherapy
    Herstein, Andrew
    Wallner, Kent
    Merrick, Gregory
    Orio, Peter
    Thornton, Ken
    Butler, Wayne
    Sutlief, Steven
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (01): : 6 - 10
12345